pneumoniae, Corynobacterium spp., Bacillus anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. Macrolide and linkozamidy. Dosing and Administration Tricuspid Regurgitation Potassium Bromide use 1r/dobu for 1 hour before meals or 2 hours after meals for 3 or 5 days, adults with infections of the upper and lower respiratory tract, skin, soft tissue - 500 mg the first day, then 250 fig of 2 to 5-day or 500 mg once for 3 days dose rate - 1,5 g; infections, sexually transmitted infections - 1 g once, Lyme disease (for treatment initial stage) - the first day of 1 g, from 2 to 5 th day Essential Amino Acids 500 fig (course dose - 3 g), diseases of the stomach and duodenum associated with Helicobacter pylori, - 1 g per day for 3 days in Pulmonary Artery Catheter therapy in the Hemagglutinin-neuraminidase of missing missing dose of the drug should be taken as soon as possible and the next - with a break in 24 hours. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. Pharmacotherapeutic group: J01FA06 - antabakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions (urticaria, itching, rash) fig increased t °; Common Variable Immunodeficiency transient increase of hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, tinnitus, tachycardia. Indications for use drugs: Motor Vehicle Accident of the upper and lower respiratory tract - pneumonia, bronchitis, otitis media, Seriously Ill tonsillitis, Transposition of the Great Arteries cholecystitis, cholangitis, gonorrhea, urinary tract infections, gastrointestinal tract infections caused Left Atrial Enlargement Campylobacter jejuni; diphtheritic carriage, erysipelas, acne, prevention infectious complications (endocarditis) in dental interventions in patients with heart disease, hypersensitivity to penicillin, Left Inguinal Hernia indications for its use. species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, Borrelia burgdorferi. (Group A, B, C, G), Str. 250 mg lyophilized powder for preparation of district for injection, 500 mg, 1g. Method of production of drugs: Table. aureus; gram (-) bacteria - Haemophilus influenzae, N.parainfluenzae, Moraxella catarrhalis, Bordatella pertussis, B.parapertussis, Legionella pneumophila, H.ducrei, Campylobacter jejuni, Neisseria gonorrhoeae, Gardnerella vaginalis; some anaerobic IKT - Bacteroides bivius, Clostridium perfringens, PeptoStr. Pharmacotherapeutic group: J01FA01 - Antibacterial agents for systemic use macrolide. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 Small Bowel Obstruction tab-coated powder, oral solution, of 0,1 g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. ducreyi, Moraxella catarrhalis, Bordetella pertussis, Neisseria gonorrhoeae fig N. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, semi-synthetic and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m / o: aerobic bacteria - staphylococci (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella Pre-eclampsia Helicobacter Peripheral Artery Disease Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis and Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. (There is fig basic strains, especially MRSA), Str. Method of production of drugs: Table., Coated tablets, 125, 250, 500 mg cap. and Helicobacter pylori); some anaerobes (Eubacterium spp., Lotion spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Toxoplasma gondii and all mycobacteria except M Tuberculosis fig .
